Miocamycin is a macrolide type antimicrobial. This drug may be marketed in Japan for clinical use as it is listed in the Japanese pharmacopeia. It has shown to be effective against several gram-positive and gram-negative microbes and may be useful in the treatment of upper and lower respiratory tract infections, and urogenital tract infections or as an alternative to erythromycin treatment. A macrolide antibiotic that has a wide antimicrobial spectrum and is particularly effective in respiratory and genital infections. It is grouped under the following drug class(es): Macrolides. Its therapeutic use is listed as antibacterials and antibiotics. The directory classifies it as a unknown/inactive API with a semi-synthetic source/manufacturing origin. Other names for this substance include midecamycin acetate, Acecamycin, Ponsinomycin and Miokamycin. Its PubChem CID is 5282188.
Miocamycin
| CAS No | 55881-07-7 |
|---|---|
| Molecular Formula | C45H71NO17 |
| Molecular Weight | 898.0 g/mol |
| Synonyms | [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-10-acetyloxy-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4-acetyloxy-4,6-dimethyl-5-propanoyloxyoxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl] propanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Miocamycin is a macrolide type antimicrobial. This drug may be marketed in Japan for clinical use as it is listed in the Japanese pharmacopeia.
The listed CAS number is 55881-07-7.
The listed molecular formula is C45H71NO17.
The listed molecular weight is 898.0 g/mol.
[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-10-acetyloxy-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4-acetyloxy-4,6-dimethyl-5-propanoyloxyoxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl] propanoate.
The source lists midecamycin acetate, Acecamycin, Ponsinomycin and Miokamycin.